Core Viewpoint - XP Inc. is facing serious allegations of operating a Ponzi-like scheme, leading to a significant decline in its share price after a report by Grizzly Research was published [1][3]. Group 1: Allegations and Investigations - A report titled "XP's Entire Profits Are Dependent on What Insiders Call a 'Madoff-Like Ponzi Scheme'" was published by Grizzly Research, causing XP's share price to drop over 5% [1][3]. - Hagens Berman, a prominent investor rights firm, is investigating the allegations and is encouraging affected investors to submit their losses [1][2]. - The investigation is focused on the accuracy of XP's statements regarding its business model and its internal financial controls [2][3]. Group 2: Details of the Allegations - The report claims that XP is running a massive Ponzi scheme through certain derivatives sales to retail clients, misrepresented as proprietary trading profits [7]. - A specific fund, GLADIUS FIM CP IE, reportedly returned over 2,419% over five years with low volatility, raising questions about its legitimacy [7]. - The profitability of XP is allegedly dependent on the sales of a product called COE (Certificado de Operações Estruturadas), which is aggressively marketed to Brazilian retail clients [7]. - Former employees indicated that the scheme relies on continuous inflows of COEs, and a halt in sales could lead to significant liabilities for XP [7].

NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XP Inc. ("XP" or the "Company") (NASDAQ: XP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether XP and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On March 12, 2025, Grizzly Research publishe ...

Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle Peyton Pomerantz LLP dpeyton@pomlaw.com 646-581-9980 ext. 7980 Following publication of the report, XP's stock price fell $0.82 per share, or 5.48%, to close at $14.14 per share on March 12, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late ...

XP Inc.A (XP) closed the last trading session at $14.67, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $20.13 indicates a 37.2% upside potential.The average comprises eight short-term price targets ranging from a low of $13 to a high of $30, with a standard deviation of $5.94. While the lowest estimate indicates a decline of 11.4% from the current price level, the mo ...

Shares of XP Inc.A (XP) have been struggling lately and have lost 5.3% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stoc ...

NEW YORK, March 24, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of XP Inc. (NASDAQ: XP) resulting from allegations that XP may have issued materially misleading business information to the investing public.So What: If you purchased XP securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is pr ...

Core Viewpoint - XP Inc.A (XP) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates for the company [1][3]. Estimate Revisions - The rising trend in earnings estimate revisions reflects growing analyst optimism, which is expected to positively impact the stock price [2]. - For the current quarter, the earnings estimate is $0.38 per share, indicating a +2.7% change from the previous year, with a 9.09% increase in the Zacks Consensus Estimate over the last 30 days [4]. - For the full year, the earnings estimate stands at $1.62 per share, representing a +5.19% change from the year-ago figure, with a 7.35% increase in the consensus estimate due to two upward revisions [5]. Zacks Rank - XP Inc.A currently holds a Zacks Rank 1 (Strong Buy), indicating strong agreement among analysts in raising earnings estimates, which historically correlates with outperformance [3][6]. - Stocks with Zacks Rank 1 and 2 have shown significant outperformance compared to the S&P 500 [6]. Stock Performance - The stock has appreciated by 5.8% over the past four weeks due to strong estimate revisions, suggesting potential for further upside [7].

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of XP Inc. due to allegations of misleading business information [1] Group 1: Legal Action and Investor Rights - Shareholders who purchased XP securities may be entitled to compensation through a class action without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 2: Allegations Against XP Inc. - A report by Grizzly Research claims that XP is running a Ponzi scheme, with profits misrepresented as proprietary trading profits [3] - Following the report, XP's stock price fell by 5.4% on March 12, 2025 [3] Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors [4] - The firm was ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions for investors over the years [4]

Core Insights - The article emphasizes the importance of in-depth research and insights for informed investment decisions in the Latin American equity market [1]. Group 1 - The company has over 5 years of experience in equity analysis specifically focused on Latin America [1]. - The research provided aims to assist clients in making informed investment decisions [1].